Table:
begin	end	state
1	21	non-cytoplasmic
22	42	transmembrane
43	54	cytoplasmic
55	78	transmembrane
79	98	non-cytoplasmic
99	126	transmembrane
127	137	cytoplasmic
138	157	transmembrane
158	173	non-cytoplasmic
174	195	transmembrane
196	230	cytoplasmic
231	249	transmembrane
250	254	non-cytoplasmic
255	272	transmembrane
273	278	cytoplasmic
279	304	transmembrane
305	315	non-cytoplasmic
316	341	transmembrane
342	346	cytoplasmic
347	368	transmembrane
369	379	non-cytoplasmic
380	399	transmembrane
400	410	cytoplasmic
411	432	transmembrane
433	435	non-cytoplasmic

Input:
>AO353_11040
MLTFLGFAMVITFMYLIMTKRLSALIALIIVPILFALFGGFAPKIGPMMLEGITKLAPTG
VMLMFAILYFALMIDSGLFDPAVRKILKLVKGDPLKVSVGTAVLALVVSMDGDGATTYMI
CVAAMLPLYSRIGMSPRIMAGLIILAGGVMNMTPWGGPTARAASALHVDPSDIFVPMIPA
MLAGVVAILAIAYLYGKRERARLGELHLIGDEIDHSEISVSQFPDARRPKLIWFNGALTL
ALMCALIAGLLPLPVLFMVAFSIAMIVNYPCLQQQKDRVAAHAGSVLAVVGLIFAAGIFT
GILSGTGMVDAMSKSLLAVIPDFLGPYLAVITALASMPFTFFMSNDAFYYGVLPVLAEAA
SHYGITAVEMARASIVGQPVHLLSPLVPSTYLLVALAGIEFGDHQRFTLKWAVLVCMCIL
VAALLMGIFPLFSTL

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server